Suzanne Blaug joined Amgen in Thousand Oaks, California, as Senior Vice President of Global Marketing and Commercial Development in April 2012. In this role, Blaug is responsible for providing commercial leadership and influencing key decisions for Amgen products at all stages of the product lifecycle and for maximizing the value of each individual franchise. Prior to joining Amgen, Blaug was the head of Janssen Alzheimer Immunotherapy Research & Development, LLC, a Johnson & Johnson company in South San Francisco, California. Prior to joining Janssen Al, she served as vice president, Strategic Marketing of Janssen EMEA, where she helped drive growth of a number of brands, as well as the successful launches of new franchises. She joined Johnson & Johnson in 2004 as area managing director. Blaug received a BS from the University of North Carolina in Chapel Hill and an MBA in Marketing & Finance from JL Kellogg Graduate School of Management, Northwestern University in Evanston, Illinois. Blaug has worked in the pharmaceutical and biotechnology industry for more than 20 years.

 Nephrology